Cargando…

An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers

Detalles Bibliográficos
Autores principales: Oosterlinck, Willem, Decaestecker, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323289/
https://www.ncbi.nlm.nih.gov/pubmed/30687601
http://dx.doi.org/10.21037/tau.2018.10.07
_version_ 1783385733254348800
author Oosterlinck, Willem
Decaestecker, Karel
author_facet Oosterlinck, Willem
Decaestecker, Karel
author_sort Oosterlinck, Willem
collection PubMed
description
format Online
Article
Text
id pubmed-6323289
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-63232892019-01-25 An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers Oosterlinck, Willem Decaestecker, Karel Transl Androl Urol Editorial AME Publishing Company 2018-12 /pmc/articles/PMC6323289/ /pubmed/30687601 http://dx.doi.org/10.21037/tau.2018.10.07 Text en 2018 Translational Andrology and Urology. All rights reserved.
spellingShingle Editorial
Oosterlinck, Willem
Decaestecker, Karel
An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
title An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
title_full An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
title_fullStr An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
title_full_unstemmed An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
title_short An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
title_sort immediate intravesical instillation of mitomycin c is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323289/
https://www.ncbi.nlm.nih.gov/pubmed/30687601
http://dx.doi.org/10.21037/tau.2018.10.07
work_keys_str_mv AT oosterlinckwillem animmediateintravesicalinstillationofmitomycincisofbenefitinallprognosticriskgroupswithnonmuscleinvasivebladdercancers
AT decaesteckerkarel animmediateintravesicalinstillationofmitomycincisofbenefitinallprognosticriskgroupswithnonmuscleinvasivebladdercancers
AT oosterlinckwillem immediateintravesicalinstillationofmitomycincisofbenefitinallprognosticriskgroupswithnonmuscleinvasivebladdercancers
AT decaesteckerkarel immediateintravesicalinstillationofmitomycincisofbenefitinallprognosticriskgroupswithnonmuscleinvasivebladdercancers